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Abstract
Menthol-sensitive/capsaicin-insensitive neurons (MS/CI) and menthol-sensitive/capsaicin-sensitive neurons (MS/CS)
are thought to represent two functionally distinct populations of cold-sensing neurons that use TRPM8 receptors
to convey innocuous and noxious cold information respectively. However, TRPM8-mediated responses have not
been well characterized in these two neuron populations. Using rat dorsal root ganglion neurons, here we show
that MS/CI neurons had larger menthol responses with greater adaptation. In contrast, MS/CS neurons had smaller
menthol responses with less adaptation. All menthol-sensitive neurons showed significant reduction of menthol
responses following the treatment of cells with the protein kinase C (PKC) activator PDBu (Phorbol 12,13-dibuty-
rate). PDBu-induced reduction of menthol responses was completely abolished in the presence of PKC inhibitors
BIM (bisindolylmaleimide) or staurosporine. When menthol responses were examined in the presence of protein
kinase inhibitors, it was found that the adaptation was significantly attenuated by either BIM or staurosporine and
also by the Ca
2+/calmodulin-dependent protein kinase (CamKII) inhibitor KN62 (N,O-bis(5-isoquinolinesulfonyl)-N-
methyl-L-tyrosyl]-4-phenylpiperazine) in MS/CI neurons. In contrast, in MS/CS neurons menthol response was not
affected significantly by BIM, staurosporine or KN62. In both MS/CI and MS/CS neurons, the menthol responses
were not affected by PKA activators forskolin and 8-Br-cAMP (8-Bromoadenosine-3’,5 ’-cyclic monophosphate) or by
protein kinase A (PKA) inhibitor Rp-cAMPs (Rp-Adenosine-3’,5’-cyclic monophosphorothioate). Taken together, these
results suggest that TRPM8-mediated responses are significantly different between non-nociceptive-like and noci-
ceptive-like neurons.
Background
Transient receptor potential M8 (TRPM8) receptor, first
cloned by MacKemy and colleagues [1] as well as Peier
and colleagues [2] from primary afferent neurons of rats
and mice, is a principal sensor for cold temperature and
belongs to the transient receptor potential (TRP) protein
family. Like most of other members in TRP family,
TRPM8 is a membrane ion channel that can allow posi-
tively charged ions (Na
+,C a
2+,K
+) to flow through cell
membranes when the channel opens. The TRPM8 chan-
nel opens when temperature drops below 26 ± 2°C,
resulting in depolarizing membrane currents [1-3].
Membrane currents flowing through TRPM8 channels
increase with decreasing temperature and reach
maximum response near 10°C. TRPM8 senses tempera-
ture changes in the range of both innocuous cold (28-
15°C) and noxious cold (<15°C) [1-3]. Activation of
TRPM8 can result in a large increase of intracellular
Ca
2+ levels due to the high Ca
2+ permeability of this
channel [1,2,4,5]. TRPM8 can also be activated by
menthol, an active ingredient of peppermint that
produces a cooling sensation [1,2,6,7].
TRPM8 receptors are expressed on 10-15% of the
t o t a lt r i g e m i n a lg a n g l i o n( T G )n e u r o np o p u l a t i o na n d
5-10% of dorsal root ganglion (DRG) neuron popula-
tion [1,2,7,8]. Consistently, the percentage of menthol-
sensitive cells in acutely dissociated rat DRG neurons
is similar to that of TRPM8-expressing DRG neurons
[9,10]. Many TRPM8-expression neurons are found to
lack nociceptive markers, suggesting that they are non-
nociceptive cold sensing neurons [2]. However, studies
have provided anatomical evidence showing TRPM8
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potential V1)-expressing afferent neurons [7,8].
TRPV1-expressing neurons are believed to be nocicep-
tive afferent neurons that transmit noxious signals to
produce burning pain sensations [11-13]. Using cal-
cium imaging and patch-clamp recording techniques,
Xing and colleagues [9] have found that a subpopula-
tion of menthol-sensitive neurons is also sensitive to
capsaicin, a noxious stimulant that acts on TRPV1
receptors. Consistent with these observations, co-
expression of TRPM8 and TRPV1 have been directly
visualized in mice engineered to express enhanced
green fluorescent protein (EGFP) driven by a TRPM8
promoter [14,15]. Thus, menthol-sensitive neurons
appear to consist of both non-nociceptive and nocicep-
tive sensory neurons and may play roles in sensing
innocuous and noxious cold respectively under physio-
logical conditions [10].
TRPM8 can be regulated through second messenger
systems [16-18]. A role for the PLC/PIP2 (Phospholipase
C/phosphatidylinositol (4,5) bisphosphate) second mes-
senger pathway in regulating TRPM8 functions has been
well established [16,17,19]. It has been suggested that
Ca
2+ influx through TRPM8 channels activates a Ca
2
+-sensitive phospholipase C and the subsequent deple-
tion of PIP2 results in desensitization of TRPM8 chan-
nels [16,17,19]. Desensitization of TRPM8 channels
could also be induced by inflammatory mediators that
activate PLC to deplete PIP2 [20]. In comparison with
the PLC/PIP2 pathway, the roles of protein kinase path-
ways in regulating TRPM8 functions remain unclear.
Premkumar and colleagues [18] showed in DRG neu-
rons that PKC activators and bradykinin significantly
reduced menthol responses. Using HEK293 cells expres-
sing TRPM8, Abe and colleagues [21] also showed that
PKC activators reduced menthol responses. Other sec-
ond message pathways such as PKA have also been sug-
gested to play roles in regulating TRPM8 functions
[22,23]. These previous studies on the regulation of
TRPM8 functions were performed either using heterolo-
gous expression system or functionally unidentified sen-
sory neurons. Therefore, it is unclear if the reduction of
TRPM8 functions occurs in a similar manner across
functionally distinct populations of neurons. In addition,
previous studies did not test whether TRPM8-mediated
responses were affected by different protein kinase inhi-
bitors, a result that is essential for establishing the roles
of protein kinases in modulating TRPM8 functions. In
the present study, we addressed some of these issues by
examining menthol-responsiveness and adaptation in
menthol-sensitive/capsaicin-insensitive and menthol-
sensitive/capsaicin-sensitive neurons.
Methods
Adult Sprague Dawley rats (100-250 g, both genders)
were used in all experiments. Animal care and use con-
formed to National Institutes of Health guidelines for
care and use of experimental animals. Experimental pro-
tocols were approved by the University of Cincinnati
Institutional Animal Care and Use Committee. DRG neu-
ron cultures were prepared as described previously [4]. In
brief, rats were deeply anesthetized with isoflurane
(Henry Schein, NY.) and sacrificed by decapitation.
DRGs were rapidly dissected out bilaterally in Leibovitz
L-15 media (Fisher, GA) and incubated for 1 hour at
37°C in minimum essential medium for suspension cul-
ture (S-MEM) (Invitrogen, Grand Island, NY) with 2%
collagenase and 10% dispase and then triturated to dis-
sociate neurons. The dissociated DRG neurons were then
plated on glass coverslips pre-coated with poly-D-lysine
(PDL, 12.5 μg/ml in distilled H2O) and laminin (20 μg/ml
in Hank’s Buffered Salt Solution HBSS, BD bio-science),
and maintained in MEM (Invitrogen) culture medium
that also contained nerve growth factor (2.5 S NGF;
10 ng/ml; Roche Molecular Biochemicals, Indianapolis,
IN), 5% heat-inactivated horse serum (JRH Biosciences,
L e n e x a ,K S ) ,u r i d i n e / 5 - f l u o r o - 2 ’-deoxyuridine (10 μM),
8 mg/ml glucose, and 1% vitamin solution (Invitrogen).
The cultures were maintained in an incubator at 37°C
with a humidified atmosphere of 95% air and 5% CO2.
Unless otherwise indicated, cells were used within
72 hours after plating.
For calcium imaging experiments, the calcium indica-
tor Fluo-3 (Invitrogen) was loaded into DRG neurons
on coverslips by incubation of cells with 5 μMF l u o - 3 -
AM in normal bath solution at 37°C for 1 hour. Fluo-3-
AM stock solution was made with 20% pluronic acid
(Molecular Probes) in dimethyl sulfoxide (DMSO) and
the stock solution was diluted 1:200 with bath solution
for final use. Normal bath solution contained (in mM)
1 5 0N a C l ,5K C l ,2M g C l 2, 2 CaCl2,1 0g l u c o s e ,1 0
HEPES, pH 7.3 adjusted with NaOH, and osmolarity
320 mOsm adjusted with sucrose. After dye loading, a
coverslip was mounted on a 0.5-ml perfusion chamber
and the chamber was then placed on the stage of an
inverted Olympus IX70 microscope (Lake Success, NY).
Cells on the coverslip were continuously perfused with
normal bath solution flowing at 1 ml/min. Fluo-3 was
excited at 450 nm with a mercury lamp and fluores-
cence emission was collected at 550 nm, and the wave
lengths of excitation and emission were achieved by a
fluorescence filter set. Fluo-3 fluorescence in the cells
was detected with a peltier-cooled charge-coupled
device (CCD) camera (PentaMAX-III System, Roper
Scientific, Trenton, NJ) under a 10× objective. Images
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sure time per frame, using the MetaFluor Imaging Sys-
tem software (Molecular Devices, Downingtown, PA).
Neurons were tested for their sensitivity to menthol
(100 μM), AIT (allyl isothiocyanate, 100 μM), or capsai-
cin (0.5 μM) by applying these compounds for 10 sec-
onds. Adaptation of menthol responses was examined
by a prolonged application of menthol (100 μM) for
5 min. Effects of protein kinases on menthol responses
and adaptation were tested with 1 μM PDBu (phorbol
12,13-dibutyrate), a protein kinase C (PKC) activator,
100 μM 8-Br-cAMP (8-bromoadenosine-3′,5 ′-cyclic
monophosphate) and 10 μM forskolin, two protein
kinase A (PKA) activators, 0.5 μMs t a u r o s p o r i n e ,a
broad spectrum protein kinase inhibitor, 1 μMB I M
(bisindolylmaleimide), a specific PKC inhibitor, 25 μM
RP-cAMPs (Rp-adenosine-3′,5′-cyclic monophosphor-
othioate), a specific PKA inhibitor, and 25 μMK N - 6 2
(1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-
4-phenylpiperazine, Tocris), a specific Ca
2+/calmodulin-
dependent protein kinase (CaMKII) inhibitor. Unless
otherwise indicated, chemicals and compounds were
purchased from Sigma (St. Louis, MO). Testing solu-
tions were rapidly applied to neurons through a glass
tube (~500 μmI D )p o s i t i o n e d1 . 0m ma w a yf r o mc e l l s .
Unless otherwise indicated, testing compounds were
applied at an interval of 10 min and capsaicin was
always tested last. All experiments where pharmacologi-
cal agents were applied were done in separate dishes.
All experiments were carried out at room temperature
of ~24°C.
For most experiments, relative fluorescence intensity
(ΔF/F0) was used to represent menthol responses and
neurons with ΔF/F0 values of ≥0.2 (i.e., equal or above
20% baseline fluorescence intensity) were considered as
responsive cells [9]. Percentages of maximal ΔF/F0
values were used as changes in menthol responses. In
some experiments, intracellular Ca
2+ concentrations
([Ca
2+]) in cells were calibrated from the measured
fluorescence signals. The following equation was use for
the calibration of intracellular Ca
2+ concentrations [24]:
[Ca
2+] = Kd[(F-Fmin)/(Fmax-F)] where [Ca
2+]i st h e
concentration (nM) of intracellular Ca
2+,K di st h ed i s -
sociation constant of the dye, F is the fluorescence
intensity, Fmin is the intensity at zero [Ca
2+]a n dF m a x
is the intensity at saturated [Ca
2+]. Procedures for
obtaining Fmax and Frnin caused damage to cells and
were therefore carried out at the end of the experi-
ments. Fmax was obtained first by adding the ionophore
ionomycin (10 μM), making the cell membrane perme-
able to Ca
2+ and allowing the extracellular and intracel-
lular Ca
2+ to equilibrate. Following this, Fmin was
obtained by adding EGTA [ethylene glycol bis(~-ami-
noethyl ether)-N,N,N′,N′-tetraacetic acid; 20 mM] to
chelate all Ca
2+ inside and outside the cells. Then
MnCl2 (30 mM) was added to quench the residual fluor-
escent signals due to autofluorescence [25]. Kd value of
404 nM was used according to a previous study [26].
Changes in intracellular Ca
2+ concentrations are calcu-
lated by Δ[Ca
2+]/[Ca
2+]0, where [Ca
2+]0 is basal intracel-
lular Ca
2+ level and Δ[Ca
2+] is the difference between
intracellular Ca
2+ concentrations at a giving time point
and [Ca
2+]0. Unless otherwise indicated, data were pre-
sented as Mean ± SEM. Analysis of Variance (ANOVA)
was applied for statistic analysis of unpaired data sets of
multiple groups followed by Student-Newman-Keuls
Post Hoc Test. Student’s t-test was applied for paired
data sets. Statistical significance was considered at the
level of the p < 0.05.
Results
Menthol responses and adaptation
Menthol-sensitive neurons were identified by calcium
imaging following a brief application of 100 μM menthol
for 10 seconds. These neurons consisted of 6.56% of
total cells (n = 1475) in our DRG neuron cultures, a
result consistent with our previous study [9]. We tested
these menthol-sensitive neurons with capsaicin (0.5 μM,
10 sec) and AIT (100 μM, 10 sec) in order to see if, in
some of them, TRPM8 receptors were also co-expressed
with TRPV1 and TRPA1, two receptors believed to be
expressed in nociceptive primary afferent neurons
[12,27,28]. Based on their sensitivity to capsaicin and
AIT, menthol-sensitive neurons could be classified into
four subpopulations: menthol-sensitive/capsaicin-insen-
sitive (MS/CI, Figure 1A), menthol-sensitive/capsaicin-
sensitive (MS/CS, Figure 1B), menthol-sensitive/AIT-
insensitive (MS/AI, Figure 1A), and menthol-sensitive/
AIT-sensitive (MS/AS, Figure 1B). Of 71 menthol-sensi-
tive neurons tested with capsaicin, 56% (40/71) were
MS/CI neurons and 44% (31/71) were MS/CS neurons
(Figure 1D). Of 30 menthol-sensitive neurons tested
with AIT, 77% (23/30) were MS/AI and 23% (7/30)
were MS/AS neurons (Figure 1E). Out of 7 neurons sen-
sitive to menthol and AIT, 5 (71%) responded to capsai-
cin as well (Figure 1B) and thereby belonging to MS/CS
neuron population [27,28]. In AIT-sensitive neurons, we
also analyzed menthol-sensitivity to see if menthol sensi-
tivity and AIT sensitivity were correlated in rat DRG
neurons [29]). We found that the majority of AIT sensi-
tive neurons (83%, 35/42) were insensitive to menthol
and only small percentage of AIT-sensitive neurons
(17%, 7/42) was menthol-sensitive (Figure 1F). Of 65
cells that responded to menthol and/or AIT, only 7
(11%) responded to both. The inverse correlation
between menthol-sensitivity and AIT-sensitivity suggests
that TRPA1 is unlike to significantly account for
menthol-induced responses in our rat DRG neurons.
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among subpopulations of menthol-sensitive neurons.
Menthol responses were larger in MS/CI than in MS/
CS (Figure 1D). Similarly, menthol responses were
larger in MS/AI than in MS/AS (Figure 1E). The peak
responses to 100 μM menthol, expressed as increases
of Fluo-3 fluorescence intensity (ΔF/Fo), were 1.22 ±
0.13 (n = 40) for MS/CI and 0.70 ± 0.15 (n = 31, P
<0.05) for MS/CS (Figure 1D); 1.11 ± 0.14 (n = 23)
for MS/AI and 0.61 ± 0.14 (n =7 ,P < 0.05) for MS/
AS (Figure 1E). We also analyzed AIT responses in
both MI/AS and MS/AS neurons. Kinetics of AIT
responses in both groups was much slower (Figure
1F) than that of menthol-responses (Figure 1D,E).
The average peak response (ΔF/Fo)t o1 0 0μMA I T
was 0.80 ± 0.72 (n = 35) for MI/AS neurons, signifi-
cantly greater than that of that MS/AS neurons (0.43
± 0.06, n=7) (Figure 1D, P <0 . 0 5 ) .T h u s ,A I T
responsiveness also has inverse correlation with
menthol-sensitivity.
Figure 1 Responses to menthol, capsaicin and AIT in dorsal root ganglion neurons of rats. A, B, C) Images show Fluo-3 fluorescence
intensity (ΔF/F0) before (baseline) and following the sequential applications of menthol (100 μM, 10 s), AIT (100 μM, 10 s), and capsaicin (0.5 μM,
10 s) with a time interval of 10 min between each application. Traces alongside with each set of images are respective time-course of
fluorescence intensity (ΔF/F0) changes. The cell in A was a menthol-sensitive/AIT-insensitive/capsaicin-insensitive neuron and in B was a
menthol-sensitive/AIT-sensitive/capsaicin-sensitive neuron. The cell in C was a menthol-insensitive/AIT-sensitive/capsaicin-sensitive neuron. D, E)
Pie graphs in each panel show percentage distribution in total menthol-sensitive neurons of menthol-sensitive/capsaicin-insensitive neurons (MS/
CI, n = 40) and menthol-sensitive/capsaicin-sensitive (MS/CS, n = 31) neurons (D) as well as in total menthol-sensitive neurons of menthol-
sensitive/AIT-insensitive neurons (MS/AI, n = 23) and menthol-sensitive/AIT-sensitive (MS/AS, n = 7) neurons. (E). Traces in D show menthol
responsiveness (ΔF/F0) in MS/CI and MS/CS neurons. Traces in E show menthol responsiveness (ΔF/F0) in MS/AI and MS/AS neurons. F) Pie graph
shows percentage distribution in total AIT-sensitive neurons of menthol-insensitive/AIT-sensitive neurons (MI/AS, n = 35) and menthol-sensitive/
AIT-sensitive (MS/AS) neurons. Two traces show AIT responsiveness (ΔF/F0) in MI/AS and MS/AS neurons. Scale bar in each image is 20 μm. The
horizontal bar in each trace indicates the 10-sec drug applications. Data are mean ± SEM in C, D, E.
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CS neurons in menthol responses to brief menthol
applications, we examined whether there were also dif-
ferences between these two subpopulations of neurons
in their responses to prolonged menthol application
(100 μM, 5 min). Changes in intracellular Ca
2+ concen-
trations ([Ca
2+]) in MS/CI neurons following the pro-
longed application of menthol displayed adaptation, i.e.,
a gradual reduction of responses over time during pro-
longed menthol application (Figure 2A,B). In our study,
values of Δ[Ca
2+]/[Ca
2+]0 were in a good agreement
with the values of ΔF/Fo when menthol responses were
expressed as percent of maximal responses (Figure 2B).
Therefore, we used ΔF/Fo values as menthol responses
for most of experiments. Photobleach was estimated to
account for less than 1.2% reduction of fluorescent
intensity at the end of 5-min menthol application (See
additional file 1). During a 5-min menthol application,
the peak response (ΔF/Fo) of MS/CI neurons (1.1 ±
0.10, n = 22 cells, 10 different dishes) was significantly
larger than that of MS/CS neurons (0.71 ± 0.10, n =
18 cells, 10 different dishes, P <0 . 0 5 )( F i g u r e2 C ) ,a
result similar to menthol response after brief menthol
applications (Figure 1D). The prolonged menthol
responses seems to be mainly due to Ca
2+ entry since
menthol responses return near baseline when normal
bath solution was replaced by a Ca
2+- free bath solution
during menthol application (see additional file 2). In
both MS/CI and MS/CS neurons, menthol responses
showed adaptation. Interestingly, in the last thirty
seconds of 5-min menthol application, the response
(ΔF/Fo) of MS/CI neurons was no longer larger than
Figure 2 Menthol responses in menthol-sensitive/capsaicin-insensitive and menthol-sensitive/capsaicin-sensitive neurons following
prolonged menthol application. A) Time course of the changes of intracellular Ca
2+ concentrations ([Ca
2+]) in MS/CI neurons (n = 22)
following the application of 100 μM menthol for 5 min. B) Menthol responses in MS/CI neurons expressed as percentages of maximal Δ[Ca
2
+]/[Ca
2+]0 values or maximal ΔF/Fo values. C) Time course of menthol responses (ΔF/Fo) in MS/CI (n = 22) and MS/CS (n = 18) neurons during 5-
min application of 100 μM menthol. D) Same as C except menthol responses at each time point are expressed as percent of peak menthol
responses. In each experiment, menthol was continuously applied for 5 min. Capsaicin-sensitivity for each cell was tested 10 min after the
termination of menthol applications. The horizontal bar in each figure indicates 5-min menthol application. Data are mean ± SEM; *P < 0.05.
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Page 5 of 13that of MS/CS neurons (Figure 2C), indicating a differ-
ent degree of adaptation between MS/CI neurons and
MS/CS neurons. The rate of adaptation could be more
clearly observed when menthol response at each
time point was expressed as percent of peak response
(Figure 2D). For example, at the end of 5-min menthol
application, the relative menthol response was 44.5 ±
4.6% (n = 22) in MS/CI neurons and was significant
smaller than that in MS/CS neurons (63.8 ± 6.0%, n=
18, P < 0.05). The differences between MS/CI and MS/
CS neurons were unlikely due to their potential differ-
ences in buffering or extruding intracellular Ca
2+
because we did not observe a significant difference
between the two groups of neurons in their responses to
5-min applications of 30 mM KCl (see additional file 3).
Taken together, these results indicated that MS/CI
neurons had a greater adaptation rate in menthol
responses than MS/CS neurons (Figure 2D).
Given the difference in peak response and adaptation
rate between MS/CI and MS/CS neurons, we next
examined recovery of menthol response after adaptation.
This was achieved by testing menthol response to brief
menthol application (100 μM, 10 s) at 5 and 15 minutes
after the end of prolonged menthol application (Figure
3A). As shown in Figure 3B, C, menthol responses were
32.3 ± 7.2% (ΔF/Fo: 0.45 ± 0.13, n = 6 cells, 3 dishes) of
peak responses in MS/CI at the end of 5-min menthol
application. After washing cells in normal bath solution
for 5 min, menthol responses slightly increased, but
w e r en o ts i g n i f i c a n t l yd i f f e r e n tf r o mt h er e s p o n s e sa t
the end of 5-min menthol application. After washing
cells in normal bath solution for 15 min, menthol
responses recovered to 72.0 ± 10.2% (ΔF/Fo: 1.02 ±
0.20, n = 6) of peak responses, significantly higher (p <
0.05) than the responses at the end of 5-min menthol
application for MS/CI neurons. For MS/CS neurons,
recovery from adaptation reached 88.2 ± 8.9% (n = 8
cells, 3 dishes) of peak responses after 15 min washing
in normal bath solution. Brief menthol application (100
μM, 10 s) did not lead to any reduction of menthol
response upon repeated menthol applications at 5 and
10 minute intervals in either MS/CI (n=12 cells, 7
dishes) or MS/CS neurons (n=11 cells, 7 dishes) (Fig-
ure 4). Thus, a time interval of longer than 5 min during
multiple brief menthol applications is a suitable para-
digm for testing recovery of menthol responses (Figure
3) and for some other experiments described below.
Effects of protein kinase activators
We examined whether in our MS/CI and MS/CS DRG
neurons, direct activation of PKC with phorbol 12,13-
dibutyrate (PDBu) significantly affect menthol-elicited
responses. As shown in Figure 5, peak menthol response
(ΔF/Fo) was reduced significantly from 0.86 ± 0.13 in
control to 0.25 ± 0.10 (n = 9 cells, 3 dishes, p <0 . 0 1 )
after treatment of cells with 1 μM PDBu for 5 min (Fig-
ure 5D). When expressed as percentage of peak
response of control, menthol response was only 28.1 ±
9.8% of control following PDBu treatment (Figure 5E).
The inhibitory effect of PDBu was observed in every cell
tested regardless whether they were MS/CI (29.8 ±
16.1%, n = 5) or MS/CS neurons (26.0 ± 11.8%, n = 4).
The effect of PDBu was most likely due to its activation
of PKC since PDBu had no significant effect on
menthol-elicited responses when cells were incubated,
prior to the application of PDBu, with either the potent
protein kinase inhibitor staurosporine (0.5 μM, 10 min)
(ΔF/Fo: 0.88 ± 0.22, 89.79 ± 16.3% of control, n=6
cells, 2 dishes) or the specific PKC inhibitor BIM (1 μM,
10 min) (ΔF/Fo: 0.82 ± 0.15, 87.6 ± 14.9% of control,
n=13 cells, 4 dishes) (Figure 5D,E). Menthol-induced
responses were not significantly altered when cells were
only treated with BIM (1 μM, 10 min) (ΔF/Fo: 1.19 ±
0.20, 102.5 ± 10.0% of control, n=14 cells, 4 dishes) or
staurosporine (0.5 μM, 10 min) (ΔF/Fo: 1.22 ± 0.12,
123.0 ± 33.1% of control, n=24 cells, 7 dishes).
We examined whether PKA activation may have an
effect on menthol response (Figure 6). Menthol response
was first tested by a brief menthol application (100 μM,
10 s) as control. Subsequently, PKA activator 8-Br-
cAMP (100 μM) or Forskolin (10 μM) was applied to
the cells for 10 min. Following this treatment, menthol
response was tested again by a brief menthol application
(100 μM, 10 s) in the presence of 8-Br-cAMP (100 μM)
or Forskolin (10 μM). Menthol responses were 133.2 ±
30.3% (n = 8 cells, 3 dishes) and 119.3 ± 13.8% (n = 6
cells, 2 dishes) of controls following the treatment of
cells with 8-Br-cAMP (100 μM) or forskolin respec-
tively, which were not significantly different from con-
trol group (Figure 6C).
Effects of protein kinase inhibitors
We asked whether PKC, CaMKII, and PKA may play a
role in shaping TRPM8-meidated responses during pro-
longed TRPM8 activation in both MS/CI and MS/CS
neurons. This was achieved by testing effects of protein
kinase inhibitors on menthol responses following pro-
longed menthol applications (Figure 7). In MS/CI neu-
rons of control group for which cells were not treated
with protein kinase inhibitors, menthol responses
showed significant adaptation and the responses were
reduced to 44.5 ± 4.6% (n = 22 cells, 10 dishes) of peak
response at the end of 5-minute menthol application
(Figure 7A, also Figure 2D). In the MS/CI neurons trea-
ted with staurosporine (0.5 μM, 10 min), PKC inhibitor
BIM (1 μM, 10 min), or CaMKII inhibitor KN62 (25 μM,
10 minutes), the adaptation following prolonged menthol
application was significantly attenuated (Figure 7A). For
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Page 6 of 13example, at the end of 5-minute menthol application,
menthol-induced responses were 75.8 ± 4.3% (n = 10
cells, 5 dishes) when cells were treated with staurospor-
ine, 66.7 ± 5.2% (n = 10 cells, 5 dishes) when cells were
treated with BIM, 63.4 ± 4.9% (n = 10 cells, 3 dishes)
when cells were treated with KN62; the responses under
these conditions were all significantly larger than that of
control group (P < 0.05). In the MS/CI neurons treated
with PKA inhibitor RP-cAMPs (25 μM, 10 minutes), no
significant difference was observed in menthol responses
at any time points between control group and RP-
cAMPs-treated group (Figure 7A). For example,
menthol-evoked response was 48.6 ± 4.9% (n = 14 cells,
5d i s h e s )i nR P - c A M P s - t r e a t e dg r o u pa tt h ee n do f
5-min menthol application, and was not significantly
different from the control group (Figure 7A).
In MS/CS neurons, menthol responses were not signifi-
cantly affected by the treatment of cells with any of the
above protein kinase inhibitors (Figure 7B). For example,
at the end of 5-minute menthol application, menthol
responses were 61.4 ± 7.2% (n=10 cells, 4 dishes) in
BIM-treated MS/CS group, 71.3 ± 5.0% (n=10 cells,
4 dishes) in staurosporine-treated MS/CS group, 65.4 ±
9.2% (n=10 cells, 3 dishes) in KN62-treated group, and
Figure 3 Recovery after menthol-induced adaptation in menthol-sensitive/capsaicin-insensitive and menthol-sensitive/capsaicin-
sensitive neurons. A) Sample traces show menthol responses and adaptation in a MS/CI neuron and a MS/CS neuron following 5-min menthol
application (left panel), recovery for 5 min (middle panel) and 15 min (right panel) in normal bath. The end of 5-min menthol application is
indicated. Recovery was tested with short menthol application (10 sec). Menthol concentration was 100 μM for both prolonged and short
applications. B) Pooled results show menthol responses (ΔF/F0) in MS/CI (n = 6) and MS/CS neurons (n = 8) at the end of 5-min menthol
application, 5 min and 15 min recovery in normal bath. C) Similar to B except menthol responses were expressed as percent of maximum
menthol responses observed during 5-min menthol application. Data are mean ± SEM in B and C; *P < 0.05.
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Page 7 of 1370.4 ± 6.6% (n = 10 cells, 5 dishes) in RP-cAMPs-treated
group; the responses under above conditions were not
significantly different from controls (63.8 ± 6.0%, n=18,
10 dishes) (Figure 7B).
Discussion
In this study we demonstrated that menthol-sensitive/
capsaicin-insensitive and menthol-sensitive/capsaicin-
sensitive neurons had different degrees of responses and
adaptation to menthol, that activation of protein kinase
C, but not protein kinase A, resulted in a large reduc-
tion of menthol responses, and that protein kinase C
and CamKII inhibitors had significant effects on
menthol responses in MS/CI neurons but not in MS/CS
neurons. These results reveal some new properties of
TRPM8-mediated responses in both MS/CI and MS/CS
neurons, the two neuron populations that most likely
represent non-nociceptive cold-sensing neurons and
nociceptive cold-sensing neurons respectively [9,30].
We used menthol as a TRPM8 agonist in the present
study. Menthol has been found to interact with TRPA1
in heterologous expression systems that express mouse
and human TRPA1 [29,31], raising a possibility that
menthol responses in some cells may be mediated by
TRPA1 in our study. However, using DRG neurons
from rats, we found inverse rather than positive correla-
tion between menthol-sensitivity and AIT-sensitivity
(Figure 1E, F). Consistent with our results, low incidence
of co-activation of menthol and AIT has been previously
reported in DRG cells by others [28,32]. The low inci-
dence of co-sensitivity to menthol and AIT is unlikely
due to the failure of mentioned agonists to cross-
activate these two receptors most of the times.
Therefore, TRPA1 is unlike to significantly account for
menthol-induced responses in our rat DRG neurons.
Menthol responsiveness was found to be higher in MS/
CI neurons than in MS/CS neurons, a result consistent
with our previous study using both the calcium imaging
and patch-clamp recoding techniques on acutely disso-
ciated DRG neurons [9,10]. Decay of menthol responses
was found to be faster in MS/CI neurons than in MS/
CS neurons, suggesting that MS/CI has faster adaptation
and MS/CS has slower adaptation to menthol.
We showed that the PKC activator PDBu reduced
menthol responsiveness in DRG neurons, and that this
effect was abolished in the presence of staurosporine or
BIM. Staurosporine inhibits a number of protein kinases
including PKC, CaMKII, and tyrosine kinase (p60v-src),
but BIM is a highly selective PKC inhibitor. The effect
of these two inhibitors is consistent with a previous
study that first suggested the involvement of PKC in
regulating TRPM8 function in sensory neurons [18]. We
further showed that menthol-induced adaptation could
be significantly attenuated by staurosporine and BIM in
MS/CI neurons. The inhibitor experiments added an
important supplement to strengthen the argument that
PKC plays a role in the adaptation of menthol responses
in MS/CI neurons. In addition to PKC, we found that
the selective CaMKII inhibitor KN62 attenuated adapta-
tion of menthol responses in MS/CI neurons, suggesting
that CaMKII may play a role in regulating TRPM8 func-
tions in MS/CI neurons. In contrast to MS/CI neurons,
Figure 4 Responses to multiple brief applications of menthol. A, B) Sample traces of responses (ΔF/F0) to three brief applications of
menthol (100 μM) in MS/CI (n = 12) and MS/CS (n = 11) neurons. Time interval was 5 min between first application and second application and
was 10 min between second application and third application. Menthol was applied for 10 s each time. C) Summary of menthol responses. Data
are mean ± SEM
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Page 8 of 13menthol responses were not significantly affected by
BIM, staurosporine, or KN62 in MS/CS neurons. We
found that MS/CS neurons had smaller menthol
response with weaker adaptation. It was initially thought
that this property of MS/CS neurons might be a result
of post-transcriptional regulation of TRPM8 function by
protein kinases. However, the lack of the effects by pro-
tein kinase inhibitors on menthol responses in MS/CS
neurons does not favor this idea. Alternatively, the smal-
ler menthol responses in MS/CS neurons were due to
the relatively lower TRPM8 expression as was proposed
in our previous study [9]. The weaker adaptation
observed in MS/CS neurons could be due to the smaller
menthol responses in these neurons. However, we did
not observe a clear co-relation between the degree of
adaption and menthol responsiveness. Therefore, other
factors might account for the differences in adaption
rate between MS/CI and MS/CS neurons. One possible
factor is PIP2, because PIP2 plays an important role in
regulating TRPM8 functions and PIP2 hydrolysis
accounts for menthol-induced desensitization [16,17]. It
would be helpful in future studies to investigate whether
PIP2 levels are significantly different between MS/CS
and MS/CS neurons.
We explored potential involvement of PKA in regulat-
ing TRPM8 functions in rat DRG neurons by using both
PKA activators and inhibitors. A previous study per-
formed on HEK cells expressing TRPM8 showed that
Figure 5 Effect of PKC activator PDBu on menthol responses. A) Sample images (left) and the trace to the right show fluorescence intensity
in a cell at baseline, during menthol application, following treatment with 1 μM PDBu, and co-application of menthol with PDBu. B) Similar to A
except BIM was applied together with PDBu and the test was on a different cell. C) Similar to B except staurosporine (Sta) was tested instead
and the test was on a different cell. D, E) Pooled results show menthol responses before and after treatment with PDBu (n = 9), with PDBu in
the presence of BIM (n = 13), with PDBu in the presence of Sta (n = 6), with BIM alone (n = 14), and with Sta alone (n = 24). Menthol responses
were expressed as ΔF/F0 (D) and percent of menthol responses before treatment (E). In all cases 100 μM menthol was applied for 10 seconds.
The PKC inhibitors BIM (1 μM) and Sta (0.5 μM) were pre-applied for 10 min and then co-applied with menthol. Maximum fluorescence intensity
was used for menthol responses presented in D and E. Scale bars are 20 μm. Data are represented as mean ± SEM; *P < 0.05.
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Page 9 of 13Figure 6 Lack of effect by PKA activators on menthol responses. A, B) Traces show menthol responses in a cell before and after treatment
with 10 μM forskolin (10 min) (A) and in another cell before and after treatment with 100 μM 8-Br-cAMP (10 min) (B). Line breaks in the time
axis are equivalent to 10 minutes. The cell in B was subsequently treated with 100 μM 8-Br-cAMP plus 1 μM μM PDBu. C) Summary of menthol
responses before and after treatment with forskolin and 8-Br-cAMP. Menthol responses were expressed as percent of menthol responses before
treatment (control). Menthol was applied for 10 seconds and peak fluorescence intensity was used. Data are represented as mean ± SEM.
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TRPM8 activity induced by menthol [23]. However,
both compounds were not found to have any significant
effect on menthol responses in our work as well as in
another recent study [22]. The discrepancy could be due
to the use of different cell types. Direct inhibition of
PKA by Rp-cAMP-S did not significantly affect menthol
responses in our study, suggesting that there is no direct
connection between PKA activity and TRPM8 functions.
However, our result does not exclude the possibility that
TRPM8 activity could be regulated indirectly through
PKA pathway [22].
The differences in TRPM8-mediated responses and
adaptation in nociceptive and non-nociceptive neuron
populations may have physiological significances. Beha-
vioral responses to innocuous and noxious cold stimuli
are different and TRPM8-mediated adaptation may con-
tribute to the differences. Mammals capably adapt to
innocuous cold. On the other hand, noxious cold is
poorly adapted, which perhaps is a conserved biological
Figure 7 Effect of protein kinase inhibitors on menthol responses in MS/CI and MS/CS neurons. A) Responses of MS/CI neurons to
prolonged menthol applications (100 μM, 5 min) in control group (red, n = 22) and groups treated with 1 μM BIM (orange, n = 10), 0.5 μM Sta.
(green, n = 10), 25 μM KN62 (blue, n = 10), and 25 μM Rp-cAMP (purple, n = 14), P < 0.05. B) Responses of MS/CS neurons to prolonged
menthol applications (100 μM, 5 min) in control group (red, n = 18) and groups treated with 1 μM BIM (orange, n = 10), 0.5 μM Sta. (green,
n = 10), 25 μM KN62 (blue, n = 10), and 25 μM Rp-cAMP (purple, n = 10). In both A and B, menthol responses were expressed as percent of
peak responses. The data for control groups in both A and B are taken from those in Figure 2D. The horizontal bar in each panel indicates
duration of 5-min menthol application. Data are mean ± SEM.
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Page 11 of 13trait of mammalian sensory systems for animals to be
aware of a harmful cold environment. TRPM8-mediated
responses and adaptation in nociceptive and non-noci-
ceptive neuron populations may only partially contribute
to behavioral cold adaptation because other receptor
molecules such as TRPA1 have been reported to also
serve as cold sensors [27,33]. It would be interesting in
future research to directly demonstrate differences to
cold adaptation between nociceptive- and non-nocicep-
tive cold sensing neurons and determine if such differ-
ences contribute to behavioral cold responses and
adaptation.
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